ACADIA Pharmaceuticals Inc. ( ACAD) - Key Metrics

ACAD Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $1.79 $0.18 $0.79 $0.73
2026Q1 $1.57 $0.02 $0.20 $0.17
2025Q4 $1.68 $1.62 -$0.29 -$0.31
2025Q3 $1.65 $0.43 $0.44 $0.44
2025Q2 $1.58 $0.16 $0.38 $0.97

ACAD Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 35.14
2026Q1 0% 278.25
2025Q4 0% 4.12
2025Q3 0% 12.41
2025Q2 0% 33.70

ACAD Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.87% 0%
2026Q1 0.76% 0%
2025Q4 -1.17% 0%
2025Q3 2.05% 0%
2025Q2 4.49% 0%

ACAD

Price: $28.24

52 week price:
19.69
29.66

Earnings Per Share: 2.24 USD

P/E Ratio: 13.12

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.4 million

Ebitda: -65.6 million

Market Capitalization: 5.0 billion

Links: